Skip to content
Search

Latest Stories

Serious Shortage Protocol for Fluoxetine 30mg capsules expires on July 28

The Serious Shortage Protocol, SSP007 for Fluoxetine 30mg capsules expires at 23.59pm on Wednesday (July 28) as the Department of Health and Social Care (DHSC) has confirmed that sufficient stock is now available to meet normal demand.

DHSC said that any prescriptions for Fluoxetine 30mg capsules must be dispensed in accordance with the prescription, and the SSP012 will no longer be valid for use.


The Pharmaceutical Services Negotiating Committee has advised pharmacy teams to submit their SSP claims using the EPS token if dispensing systems do not support all the endorsement requirements to submit a valid claim.

If a pharmacy is using an EPS token to submit SSP claims, they are reminded to mark the corresponding EPS message as ‘Not Dispensed’ or ’ND’, to avoid double-claiming.

It further advised using the claim amend facility on the PMR system to rectify any incorrect EPS claims already submitted this month.

Any paper prescriptions or EPS tokens with SSP claims need to be placed in the red separator provided by the NHSBSA (and kept separate from other tokens for non-payment i.e. with paid/exempt status).

For any supplies made in accordance with SSPs, pharmacists are asked to check that the correct number of patient charges are collected and declared on the end of month FP34C submission document.

PSNC said, "Although an SSP cannot be used outside its period of validity, claims can be submitted up to three calendar months after expiry or withdrawal of the SSP. For example, for the Fluoxetine 30mg capsules, which expires on 28 July, the NHSBSA would continue to look for the “SSP” or “NCSO” endorsement on prescriptions for Fluoxetine 30mg capsules that are submitted with the July batch (submitted by the 5th of August), August batch (submitted by the 5th September) and September batch (submitted by the 5th of October).

It addedd, "Until 5th October 2021, NHSBSA will accept both the “SSP” and “NCSO” endorsement. For further information on the new endorsement requirements for this SSP."

NHSBSA advise that contractors must follow the specific endorsement guidance issued with each SSP and endorsements should be clear and unambiguous – NHSBSA processing staff must be able to determine what has been supplied.

Pharmacy contractors should keep a record of all SSP claims submitted each month to reconcile against their monthly Schedule of Payments or Prescription Item (Px) reports.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less